Skip to main content
. 2022 Jan 31;9:725169. doi: 10.3389/fcell.2021.725169

TABLE 2.

Description of the antibodies used to define ILCs.

Marker Label Source Clone Dilution
Lineage markers CD3 FITC BD UCHT1 1/40
CD19 FITC BD HIB19 1/40
CD14 FITC BD M5E2 1/100
CD11b FITC BD M1/70 1/100
CD11c FITC BD B-ly6 1/100
CD34 FITC BD 581 1/40
CD56 FITC BD B519 1/100
ILC surface markers CD45 APC-Cy7 BD 2D1 1/200
CD127 (IL7Ra) PerCP-Cy5.5 BD HIL-7R-M21 1/50
CRTH2 (CD294) PE-Cy7 BioLegend BM16 1/50
CD117 (cKit) PE BD YB5.B8 1/50
NKp44 (CD336) APC BD p44-8 1/20
ILC intracellular markers T-bet (TBX21) PE-CF594 BD O4-46 1/20
GATA3 BV421 BD L50-823 1/20
RORγt BV650 BD Q21-559 1/20
IFN-γ BV605 BD B27 1/20
IL-4 BV786 BD MP4-25D2 1/20
IL-17A BV510 BD N49-653 1/20

Note. ILCs, innate lymphoid cells; FITC, fluorescein isothiocyanate.